Clinical Drug Experience Knowledgebase

Acute Kidney Injury (Phase 4)

Adenocarcinoma (Phase 3)

Alcohol Drinking (Phase 3)

Anemia, Aplastic (Phase 2)

Attention Deficit Disorder with Hyperactivity (Phase 3)

Biliary Tract Neoplasms (Phase 3)

Carcinoma (Phase 3)

Coronary Disease (Phase 3)

Dissociative Disorders (Phase 3)

Gallbladder Neoplasms (Phase 3)

Hodgkin Disease (Phase 2)

Hypercholesterolemia (Phase 1)

Hyperglycemia (Phase 1)

Infections (Phase 3)

Keratosis (Phase 4)

Keratosis, Actinic (Phase 4)

Leukemia (Phase 3)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Malaria (Phase 4)

Melanoma (Phase 2)

Multiple Myeloma (Phase 2)

Multiple Sclerosis (Phase 2)

Multiple Sclerosis, Relapsing-Remitting (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Overweight (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Retinal Detachment (Phase 3)

Sarcoma (Phase 1)

Schizophrenia (Phase 2)

Sclerosis (Phase 2)

Sepsis (Phase 2)

Shock (Phase 3)

Shock, Septic (Phase 3)

Staphylococcal Infections (Phase 3)

Stomach Neoplasms (Phase 3)

Stroke (Phase 4)

Thrombosis (Phase 3)

Tic Disorders (Phase 3)

Tics (Phase 3)

Tobacco Use Disorder (Phase 2)

Tourette Syndrome (Phase 3)

Toxemia (Phase 2)

Venous Thromboembolism (Phase 3)

Venous Thrombosis (Phase 3)

Vitreoretinopathy, Proliferative (Phase 3)